Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Int Agency Res Cancer 2020. Available at: https://gco.iarc.fr/today/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=0&include_nmsc_other=0&projection=natural-earth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&show_ranking=0&rotate=%255B10%252C0%255D.

INCA. [Estimativa 2020: incidência de câncer no Brasil.][Article in Portuguese.] Available at: https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil

Motta RDR, Zettler CG, Cambruzzi E, et al. Ki-67 and p53 correlation prognostic value in squamous cell carcinomas of the oral cavity and tongue. Braz J Otorhinolaryngol 2009;75:544–9.

Pereira de Lima MA, CG Lima da Silva, SH Barem Rabenhorst. Association between human papillomavirus (HPV) and the oral squamous cell carcinoma: a systematic review. J Bras Patol e Med Lab 2014;50:75–84.

Chiesa F, Ostuni A, Grigolato R, et al. Head and Neck Cancer Prevention. In: Head and Neck Cancer, Springer, New York, USA, 2016, p. 41-55.

American Cancer Society. Cancer Facts & Figures 2019. Available at: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf

Garland EM, Parker LC. Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma: A Review. Physician Assist Clin 2016;1:465–77.

Young D, Xiao CC, Murphy B, et al. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol 2015;51:727–30.

Stein AP, Saha S, Kraninger JL, et al. Prevalence of Human Papillomavirus in Oropharyngeal Cancer. Cancer J 2015;21:138–46.

Sonawane K, Suk R, Chiao EY, et al. Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014. Ann Intern Med 2017;167:714.

Ndiaye C, Mena M, Alemany L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 2014;15:1319–31.

Colpani V, Soares Falcetta F, Bacelo Bidinotto A, et al. Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis. PLoS One 2020;15:e0229154.

Westra WH. Detection of human papillomavirus (HPV) in clinical samples: Evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol 2014;50:771–9.

Lewis JS, Beadle B, Bishop JA, et al. Human papillomavirus testing in head and neck carcinomas guideline from the college of American pathologists. Arch Pathol Lab Med 2018;142:559–97.

Prigge E-S, Arbyn M, von Knebel Doeberitz M, et al. Diagnostic accuracy of p16 INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis. Int J Cancer 2017;140:1186–98.

World Health Organization. 2013. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Available at: https://apps.who.int/iris/handle/10665/96612

StataCorp. 2019. Stata Statistical Software: Release 16. College Station, USA: StataCorp. LLC.

R Core Team. 2019. R: A Language and Environment for Statistical Computing. Vienna, Austria.

RStudio Team. 2018. RStudio: Integrated Development Environment for R. RStudio PBC, Boston, USA.

Anantharaman D, Abedi-Ardekani B, Beachler DC, et al. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer 2017;140:1968–75.

Barros-Filho MC, Reis-Rosa LA, Hatakeyama M, et al. Oncogenic drivers in 11q13 associated with prognosis and response to therapy in advanced oropharyngeal carcinomas. Oral Oncol 2018;83:81–90.

Betiol JC, Sichero L, Costa HO de O, et al. Prevalence of human papillomavirus types and variants and p16INK4a expression in head and neck squamous cells carcinomas in São Paulo, Brazil. Infect Agent Cancer 2016;11:20.

Brew MC, Trapp R, Hilgert JB, et al. Human papillomavirus and oral squamous cell carcinoma in a south Brazilian population. Exp Mol Pathol 2012;93:61–5.

Buexm LA, Soares-Lima SC, Brennan P, et al. HPV impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil. Cancer Lett 2020;477:70–5.

Cortezzi SS, Provazzi PJ, Sobrinho JS, et al. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 2004;150:44–9.

Da Silva CEX dos SR, Da Silva IDCG, CERRI A, et al. Prevalence of human papillomavirus in squamous cell carcinoma of the tongue. Oral Surgery, Oral Med Oral Pathol Oral Radiol Endodontology 2007;104:497–500.

de Abreu PM, Có ACG, Azevedo PL, et al. Frequency of HPV in oral cavity squamous cell carcinoma. BMC Cancer 2018;18:324.

de Carvalho AC, Perdomo S, dos Santos W, et al. Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma. Sci Rep 2020;10:9970.

De Cicco R, Melo Menezes R, Nicolau UR, et al. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV‐related cancer: A retrospective cohort study. Head Neck 2020;42:93–102.

de Freitas Cordeiro-Silva M, Stur E, Agostini LP, et al. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort. Mol Biol Rep 2012;39:10111–9.

de Spíndula-Filho JV, da Cruz AD, Oton-Leite AF, et al. Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV). Tumor Biol 2011;32:409–16.

Demathe A, Bernabé DG, Garcia JF, , et al. [Comparação entre dois métodos de detecção de DNA de papilomavírus humano em carcinoma epidermoide de lábio.][Article in Portuguese.] J Bras Patol e Med Lab 2010;46:85–90.

Fregonezi PAG, Silva TGA, Simões RT, et al. Expression of nonclassical molecule human leukocyte antigen–G in oral lesions. Am J Otolaryngol 2012;33:193–8.

Hauck F, Oliveira-Silva M, Dreyer JH, et al. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany. Virchows Arch 2015;466:685–93.

Kaminagakura E, Villa LL, Andreoli MA, et al. High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer 2012;130:1726–32.

Lira RCP, Miranda FA, Guimarães MCM, et al. BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus. Oncol Rep 2010;23:1027–36.

López RVM, Levi JE, Eluf-Neto J, et al. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer Causes Control 2014;25:461–71.

Miguel REV, Villa LL, Cordeiro AC, et al. Low prevalence of human papillomavirus in a geographic region with a high incidence of head and neck cancer. Am J Surg 1998;176:428–9.

Oliveira LR, Ribeiro-Silva A, Ramalho LN, et al. HPV infection in Brazilian oral squamous cell carcinoma patients and its correlation with clinicopathological outcomes. Mol Med Rep 2008;1:123–9.

Petito G, Carneiro MA dos S, Santos SH de R, et al. Human papillomavirus in oral cavity and oropharynx carcinomas in the central region of Brazil. Braz J Otorhinolaryngol 2017;83:38–44.

Piña AR, Jimenez LS, Mariano FV, et al. Human papillomavirus in tonsillar squamous cell carcinomas from Guatemala and Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol 2016;121:412–8.

Ribeiro MGM, Marcolino LD, Ramos BR de A, et al. High prevalence of human papillomavirus (HPV) in oral mucosal lesions of patients at the Ambulatory of Oral Diagnosis of the Federal University of Sergipe, Northeastern Brazil. J Appl Oral Sci 2017;25:69–74.

Rivero ERC, Nunes FD. HPV in oral squamous cell carcinomas of a Brazilian population: amplification by PCR. Braz Oral Res 2006;20:21–4.

Simonato LE, Garcia JF, Sundefeld MLMM, et al. Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival. J Oral Pathol Med 2008;37:593–8.

Soares CP, Malavazi I, Reis RI dos, et al. [Presença do papilomavirus humano em lesões malignas de mucosa oral.][Article in Portuguese.] Rev Soc Bras Med Trop 2002;35:439–44.

Soares RC, Oliveira MC, Souza LB, et al. Human papillomavirus in oral squamous cells carcinoma in a population of 75 Brazilian patients. Am J Otolaryngol 2007;28:397–400.

Vidal AK de L, Caldas Júnior A de F, Mello RJV de, et al. HPV detection in oral carcinomas. J Bras Patol e Med Lab 2004;40.

Castillo A, Koriyama C, Higashi M, et al. Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol 2011;17:5295.

Erira A, Motta LA, Chala A, et al. [Genotipificación, niveles de expresión y estado físico del virus del papiloma humano en pacientes colombianos con cáncer de células escamosas en la cavidad oral.][Article in Spanish.] Biomédica 2015;36:14.

Mancilla LI, Carrascal E, Mario Tamayo O, et al. Role of Human Papillomavirus Type 16 in Squamous Cell Carcinoma of Upper Aerodigestive Tracts in Colombian Patients. Int J Cancer Res 2011;7:222–32.

Quintero K, Giraldo GA, Uribe ML, et al. Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia. Braz J Otorhinolaryngol 2013;79:375–81.

Gónzalez J V., Gutiérrez RA, Keszler A, et al. [Virus papiloma humano en lesiones orales.][Article in Spanish.] Med (Buenos Aires) 2007;67:363–8.

Mosmann JP, Talavera AD, Criscuolo MI, et al. Sexually transmitted infections in oral cavity lesions: Human papillomavirus, Chlamydia trachomatis , and Herpes simplex virus. J Oral Microbiol 2019;11:1632129.

Pennacchiotti G, Sáez R, Martínez MJ, et al. [Prevalencia del virus papiloma humano en pacientes con diagnóstico de carcinoma escamoso de la cavidad oral.][Article in Spanish.] Rev Chil Cirugía 2016;68:137–42.

Reyes M, Rojas-Alcayaga G, Pennacchiotti G, et al. Human papillomavirus infection in oral squamous cell carcinomas from Chilean patients. Exp Mol Pathol 2015;99:95–9.

Premoli-De-Percoco G, Ramirez JL. High risk human papillomavirus in oral squamous carcinoma: evidence of risk factors in a Venezuelan rural population. Preliminary report. J Oral Pathol Med 2001;30:355–61.

Correnti M, Rivera H, Cavazza M. Detection of human papillomaviruses of high oncogenic potential in oral squamous cell carcinoma in a Venezuelan population. Oral Dis 2004;10:163–6.

Abogunrin S, Di Tanna GL, Keeping S, et al. Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis. BMC Cancer 2014;14:968.

Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and non-oropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2013;35:747–55.

Mariz BALA, Kowalski LP, William WN, et al. Global prevalence of human papillomavirus-driven oropharyngeal squamous cell carcinoma following the ASCO guidelines: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2020;156:103116.

Chen SY, Massa S, Mazul AL, et al. The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review. Am J Otolaryngol 2020;41:102592.

Sinha P, Karadaghy OA, Doering MM, et al. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis. Oral Oncol 2018;86:121–31.